UBS AM’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.74M | Buy |
186,698
+108,354
| +138% | +$1.01M | ﹤0.01% | 2204 |
|
|
2025
Q1 | $527K | Buy |
78,344
+20,151
| +35% | +$136K | ﹤0.01% | 2493 |
|
|
2024
Q4 | $618K | Buy |
58,193
+14,328
| +33% | +$152K | ﹤0.01% | 2516 |
|
|
2024
Q3 | $641K | Sell |
43,865
-8,189
| -16% | -$120K | ﹤0.01% | 2577 |
|
|
2024
Q2 | $630K | Buy |
52,054
+40,354
| +345% | +$488K | ﹤0.01% | 2561 |
|
|
2024
Q1 | $289K | Buy |
+11,700
| New | +$289K | ﹤0.01% | 2406 |
|